Navigation Links
AAIPharma Appoints Senior Director of Biopharmaceutical Development
Date:12/7/2012

WILMINGTON, N.C., Dec. 7, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company's senior director of biopharmaceutical development for its Wilmington, N.C. laboratory.

(Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO)

"Tim's focus on customer service and high-quality deliverables makes him a perfect fit for our organization" said Paul Maffuid, executive vice president of AAIPharma's laboratory operations. "His demonstrated leadership within the CMC analytical sector complements our service offerings and will capitalize on the recent biopharmaceutical advancements made within our Wilmington Technology Center."

Dr. Rhines joins AAIPharma with more than 22 years of experience in laboratory management, most recently with Covance Laboratories as the director of chemistry, manufacturing, and controls (CMC) pharmaceutical development services for North America.

"AAIPharma offers exceptional services and a broad expertise in the field of biopharmaceutical services.  Our vision is to continue the growth within AAIPharma's biopharmaceutical development team" Dr. Rhines said.  "AAIPharma's staff of experienced and talented scientists, coupled with recently added state of the art instrumentation within its Technology Center, will continue to establish AAIPharma as an industry leader for biopharmaceutical development and characterization."

Dr. Rhines earned his undergraduate degree in chemistry from the University of Northern Iowa, and a doctorate in analytical chemistry from the University of Iowa.  In addition, Dr. Rhines is a member of the Regulatory Affairs Professional Society, the American Association of Pharmaceutical Sciences and is a past participant in the Midwest United States Pharmacopeia Discussion Group.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit www.aaipharma.com.

 


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Director Of Analytical Chemistry
2. uniQure Appoints Hans Christian Rohde Chief Commercial Officer
3. CIVCO Medical Solutions Appoints Senior Vice President and General Managers to Business Units
4. Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
5. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
6. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
7. Positron Appoints Charles Conroy As Chief Operating Officer
8. Tris Pharma Appoints New Vice President of Business Development
9. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
10. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
11. Discovery Labs Appoints John R. Leone to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/1/2017)... 1, 2017 Michael Penna , President ... highlights opportunities for growth in his response to the ... Equity is seeking a buyer for eMDs. Penna,s company, ... healthcare solutions Value Added Reseller and national leader in ... "As the healthcare market continues to dictate ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... ... PITTSBURGH...An inventor, from Richmond Hill, Ga., thought there needed to be a quick ... invented the COMPLETE PATIENT CHART. , The COMPLETE PATIENT CHART provides a more effective ... alternative to paper charts and clipboards. As a result, it increases efficiency and it ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... science and technology-enabled services supporting clinical research, today announces that 30 of ... aspects of the drug development lifecycle at upcoming industry conferences and webinars. ...
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings to include ... the hottest Korean cosmetics and fashion trends sweeping the nation. The decision to expand ... for the great offerings that allow Koreans everywhere to look their best every single ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The Majestic Unicorn”: a poignant ... “The Majestic Unicorn” is the creation of published author, Dayna Chantel, an artist and ... far and wide to march aboard the cypress ark-vessel. Male and female, no matter ...
(Date:9/25/2017)... ... ... kill Ash trees in as little as 1-3 years. The signs of this ... Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street in Northeast Philadelphia ... decline from Emerald Ash Borers, two Ash trees continue to thrive. , "The ...
Breaking Medicine News(10 mins):